000 01836 a2200553 4500
005 20250511190137.0
264 0 _c19920908
008 199209s 0 0 eng d
022 _a0023-852X
024 7 _a10.1288/00005537-199208000-00009
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLaccourreye, O
245 0 0 _aT1 squamous cell carcinoma of the arytenoid.
_h[electronic resource]
260 _bThe Laryngoscope
_cAug 1992
300 _a896-900 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xtherapeutic use
650 0 4 _aArytenoid Cartilage
_xpathology
650 0 4 _aCarcinoma, Squamous Cell
_xdrug therapy
650 0 4 _aCisplatin
_xadministration & dosage
650 0 4 _aCobalt Radioisotopes
_xtherapeutic use
650 0 4 _aFemale
650 0 4 _aFluorouracil
_xadministration & dosage
650 0 4 _aFollow-Up Studies
650 0 4 _aHead and Neck Neoplasms
_xprevention & control
650 0 4 _aHumans
650 0 4 _aLaryngeal Neoplasms
_xdrug therapy
650 0 4 _aLaryngectomy
650 0 4 _aLymphatic Metastasis
_xprevention & control
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aNeoplasm Recurrence, Local
650 0 4 _aNeoplasm Staging
650 0 4 _aRadiotherapy Dosage
650 0 4 _aRadiotherapy, High-Energy
650 0 4 _aSurvival Rate
650 0 4 _aTreatment Outcome
650 0 4 _aVitamin B 12
_xtherapeutic use
700 1 _aWeinstein, G
700 1 _aChabardes, E
700 1 _aHousset, M
700 1 _aLaccourreye, H
700 1 _aBrasnu, D
773 0 _tThe Laryngoscope
_gvol. 102
_gno. 8
_gp. 896-900
856 4 0 _uhttps://doi.org/10.1288/00005537-199208000-00009
_zAvailable from publisher's website
999 _c1501840
_d1501840